The portfolio is powered by Enzyme, an Ethereum-based infrastructure for on-chain asset management. Enzyme connects fund managers to a pool of potential investors, making it easier to create a community.
Paraswap – $MLN farming begins today!
TL;DR; Trades via @paraswap will be partially subsidised with some $MLN tokens for a week by the exchange aggregator for Enzyme. Find out more in this blog post 👇🏾 https://t.co/QgMzil8j4e
— Enzyme Finance (@enzymefinance) February 10, 2021
Techemy is able to access deep liquidity across the entire Ethereum network thanks to Enzyme’s integration with Paraswap, a Decentralised Exchange aggregator that optimises order routing and minimises slippage.
“Following the exceptional performance of Techemy Capital’s private DeFi Portfolio in 2020, we are excited to open this product through Enzyme to the broader investor community,” said Fran Strajnar, Founder of Techemy Capital and Brave New Coin. “We are looking forward to working with Enzyme and our growing number of exchange partners to deliver the highest-grade digital asset and DeFi investment products.”
Disclaimer: The views and opinions expressed by the author should not be considered as financial advice. We do not give advice on financial products.